Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2454558 | 0.89 | HPGD (0.38) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL2454893 | 0.86 | HPGD (0.40) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL2452901 | 0.84 | HPGD (0.40) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL22462375 | 0.84 | HPGD (0.35) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL2452441 | 0.82 | KMT2A (0.42) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL24448966 | 0.82 | HPGD (0.41) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL557178 | 0.82 | HPGD (0.41) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL2452169 | 0.82 | HPGD (0.38) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL2453016 | 0.81 | HPGD (0.43) | HPGDRAB9ACYP3A4CYP2C19KMT2A | |
| SCHEMBL16138558 | 0.79 | ALDH1A1 (0.45) | HPGDRAB9AKMT2AEPHX1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115556441-B | Decorative film and method for producing decorative molded article using same | 日本聚丙烯株式会社 | 2025-04-11 | — | — | CN | disclosed |
| CN-115556441-A | Decorative film and method for producing decorative molded body using same | 日本聚丙烯株式会社 | 2023-01-03 | — | — | CN | disclosed |
| CN-115556446-A | Decorative film and method for producing decorative molded body using same | 日本聚丙烯株式会社 | 2023-01-03 | — | — | CN | disclosed |
| US-20200384678-A1 | DECORATIVE FILM AND METHOD FOR MANUFACTURING DECORATIVE MOLDED ARTICLE USING SAME | JAPAN POLYPROPYLENE CORPORATION (JP) | 2020-12-10 | — | — | US | disclosed |
| EP-3715092-A1 | DECORATIVE FILM AND METHOD FOR MANUFACTURING DECORATIVE MOLDED ARTICLE USING SAME | Japan Polypropylene Corporation (JP) | 2020-09-30 | — | — | EP | disclosed |
| EP-2862883-B1 | METHOD FOR PRODUCING NUCLEATOR MASTERBATCH | ADEKA CORP (JP) | 2019-09-25 | — | — | EP | disclosed |
| US-20160289262-A1 | BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARMACEUTICALS, INC. | 2016-10-06 | — | — | US | disclosed |
| US-9243127-B2 | Method for producing nucleator masterbatch | ADEKA CORPORATION (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20150152248-A1 | METHOD FOR PRODUCING NUCLEATOR MASTERBATCH | ADEKA CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2862883-A1 | METHOD FOR PRODUCING NUCLEATOR MASTERBATCH | Adeka Corporation (JP) | 2015-04-22 | — | — | EP | disclosed |
| EP-2615138-A1 | STEREOCOMPLEX POLYLACTIC ACID FILM AND RESIN COMPOSITION | Teijin Limited (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-20130178567-A1 | STEREOCOMPLEX POLYLACTIC ACID FILM AND RESIN COMPOSITION | TEIJIN LIMITED (JP) | 2013-07-11 | — | — | US | disclosed |
| US-20110301268-A1 | POLYPROPYLENE RESIN COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-08 | — | — | US | disclosed |
| EP-2096137-B1 | NOVEL POLYOLEFIN RESIN COMPOSITION AND MOLDED RESIN OBTAINED THEREFROM | NEW JAPAN CHEM CO LTD (JP) | 2011-09-14 | — | — | EP | disclosed |
| US-7723413-B2 | Method and composition for control of crystallization rate of polyolefin resin, resin composition and resin molding | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-1715000-B1 | METHOD AND COMPOSITION FOR CONTROL OF CRYSTALLIZATION RATE OF POLYOLEFIN RESIN, RESIN COMPOSITION AND RESIN MOLDING | NEW JAPAN CHEM CO LTD (JP) | 2010-03-10 | — | — | EP | disclosed |
| US-20100016491-A1 | NOVEL POLYOLEFIN RESIN COMPOSITION AND MOLDED RESIN OBTAINED THEREFROM | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2096137-A1 | NOVEL POLYOLEFIN RESIN COMPOSITION AND MOLDED RESIN OBTAINED THEREFROM | New Japan Chemical Co., Ltd. (JP) | 2009-09-02 | — | — | EP | disclosed |
| US-20070142514-A1 | Method and composition for control of crystallization rate of polyolefin resin, resin composition and resin molding | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1715000-A1 | METHOD AND COMPOSITION FOR CONTROL OF CRYSTALLIZATION RATE OF POLYOLEFIN RESIN, RESIN COMPOSITION AND RESIN MOLDING | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2006-10-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289262-A1 | BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF | GPBAR1, NR1H4, SLC10A1 | HPGD 1549/4885RAB9A 1942/4885CYP3A4 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.